226 related articles for article (PubMed ID: 25211284)
21. A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection.
Li XL; Wei HX; Zhang H; Peng HJ; Lindsay DS
PLoS One; 2014; 9(5):e97775. PubMed ID: 24830795
[TBL] [Abstract][Full Text] [Related]
22. [Toxoplasma infections in early pregnancy: consequences and management].
Wallon M; Gaucherand P; Al Kurdi M; Peyron F
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
[TBL] [Abstract][Full Text] [Related]
23. Congenital toxoplasmosis: What is the evidence for chemoprophylaxis to prevent fetal infection?
Mandelbrot L
Prenat Diagn; 2020 Dec; 40(13):1693-1702. PubMed ID: 32453454
[TBL] [Abstract][Full Text] [Related]
24. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
Foulon W; Villena I; Stray-Pedersen B; Decoster A; Lappalainen M; Pinon JM; Jenum PA; Hedman K; Naessens A
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):410-5. PubMed ID: 9988811
[TBL] [Abstract][Full Text] [Related]
25. Congenital toxoplasmosis: therapeutic strategies.
Foulon W
Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
[No Abstract] [Full Text] [Related]
26. Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection.
Robert-Gangneux F; Yera H; D'Herve D; Guiguen C
Pediatr Infect Dis J; 2009 Jul; 28(7):660-1. PubMed ID: 19561432
[TBL] [Abstract][Full Text] [Related]
27. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
[TBL] [Abstract][Full Text] [Related]
28. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
[TBL] [Abstract][Full Text] [Related]
29. [Congenital toxoplasmosis retinochoroiditis after primary infection of the mother in pregnancy].
Kuchar A; Hayde M; Steinkogler FJ
Ophthalmologe; 1996 Apr; 93(2):190-3. PubMed ID: 8652987
[TBL] [Abstract][Full Text] [Related]
30. The placenta: a main role in congenital toxoplasmosis?
Robert-Gangneux F; Murat JB; Fricker-Hidalgo H; Brenier-Pinchart MP; Gangneux JP; Pelloux H
Trends Parasitol; 2011 Dec; 27(12):530-6. PubMed ID: 22079164
[TBL] [Abstract][Full Text] [Related]
31. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of congenital toxoplasmosis].
Russo M; Galanti B
Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
[TBL] [Abstract][Full Text] [Related]
33. [Management of congenital toxoplasmosis in France: current data].
Garcia-Méric P; Franck J; Dumon H; Piarroux R
Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
[TBL] [Abstract][Full Text] [Related]
34. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid.
Gratzl R; Hayde M; Kohlhauser C; Hermon M; Burda G; Strobl W; Pollak A
Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):853-8. PubMed ID: 10052549
[TBL] [Abstract][Full Text] [Related]
35. Management of toxoplasmosis.
Georgiev VS
Drugs; 1994 Aug; 48(2):179-88. PubMed ID: 7527323
[TBL] [Abstract][Full Text] [Related]
36. Toxoplasmosis and pregnancy.
Chaudhry SA; Gad N; Koren G
Can Fam Physician; 2014 Apr; 60(4):334-6. PubMed ID: 24733322
[TBL] [Abstract][Full Text] [Related]
37. [Toxoplasmosis in pregnancy: Practical Management].
Mandelbrot L; Kieffer F; Wallon M; Winer N; Massardier J; Picone O; Fuchs F; Benoist G; Garcia-Meric P; L'Ollivier C; Paris L; Piarroux R; Villena I; Peyron F
Gynecol Obstet Fertil Senol; 2021 Oct; 49(10):782-791. PubMed ID: 33677120
[TBL] [Abstract][Full Text] [Related]
38. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection.
Couvreur J; Desmonts G; Thulliez P
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():193-200. PubMed ID: 3182443
[TBL] [Abstract][Full Text] [Related]
39. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
Gras L; Gilbert RE; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
[TBL] [Abstract][Full Text] [Related]
40. [Congenital toxoplasmosis and seroconversion at the end of pregnancy: clinical observations].
Luyasu V; Bauraind O; Bernard P; Bietlot Y; Brasseur C; Englebert J; Fiasse L; Givron O; Longueville E; Melard JL; Michel M; Wacquez M
Acta Clin Belg; 1997; 52(6):381-7. PubMed ID: 9489134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]